FEN also inhibited the elevation in hepatic and adipose Fgf21 induced by obesity and impaired glucose homeostasis in Leprdb mice, demonstrating that the effects of FEN on Fgf21 gene expression are common to both diet- and genetically-induced obesity. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.